These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3552773)

  • 21. Clinical courses and changes of pancreatic beta-cell function in young-onset diabetics: report of two cases.
    Hwang JS; Juang JH
    Changgeng Yi Xue Za Zhi; 1998 Sep; 21(3):328-32. PubMed ID: 9849016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine C-peptide, beta-cell function, and insulin requirement.
    Rappaport EB; Ulstrom RA; Etzwiler DD; Fife D; Hedlund BE; Steffes MW
    Am J Dis Child; 1980 Dec; 134(12):1129-33. PubMed ID: 7004175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postprandial 2-hr C-peptide concentration as a guide for insulin treatment in patient with NIDDM.
    Kim RS; Yang IM; Kim JW; Kim YS; Kim KW; Kim SW; Choi YK
    Korean J Intern Med; 1986 Jan; 1(1):120-5. PubMed ID: 15759387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-cell function in pancreatic adenocarcinoma.
    Basso D; Plebani M; Fogar P; Del Favero G; Briani G; Meggiato T; Panozzo MP; Ferrara C; D'Angeli F; Burlina A
    Pancreas; 1994 May; 9(3):332-5. PubMed ID: 8022755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementing a Reference Measurement System for C-Peptide: An Addendum.
    Little RR; Kinumi T; Connolly S; Kabytaev K
    Clin Chem; 2017 Dec; 63(12):1904-1905. PubMed ID: 28978561
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of appropriate biochemical parameters and cut points to detect Maturity Onset Diabetes of Young (MODY) in Asian Indians in a clinic setting.
    Aarthy R; Aston-Mourney K; Amutha A; Mikocka-Walus A; Anjana RM; Unnikrishnan R; Jebarani S; Venkatesan U; Gopi S; Radha V; Mohan V
    Sci Rep; 2023 Jul; 13(1):11408. PubMed ID: 37452084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-Based Differences in Clinical Profile and Complications among Individuals with Type 2 Diabetes Seen at a Private Tertiary Diabetes Care Centre in India.
    Pradeepa R; Shreya L; Anjana RM; Jebarani S; Venkatesan U; Kamal Raj N; Swami OC; Mohan V
    Healthcare (Basel); 2023 Jun; 11(11):. PubMed ID: 37297774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study.
    Anjana RM; Baskar V; Nair ATN; Jebarani S; Siddiqui MK; Pradeepa R; Unnikrishnan R; Palmer C; Pearson E; Mohan V
    BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32816869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum adiponectin helps to differentiate type 1 and type 2 diabetes among young Asian Indians.
    Gokulakrishnan K; Aravindhan V; Amutha A; Abhijit S; Ranjani H; Anjana RM; Unnikrishnan R; Miranda P; Narayan KM; Mohan V
    Diabetes Technol Ther; 2013 Aug; 15(8):696-702. PubMed ID: 23902401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India.
    Mohan V; Meera R; Premalatha G; Deepa R; Miranda P; Rema M
    Postgrad Med J; 2000 Sep; 76(899):569-73. PubMed ID: 10964123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters].
    Santoro E; Gianni R; Maggi L; Tomassini CR; Bisacchi U
    G Clin Med; 1989 Feb; 70(2):95-9. PubMed ID: 2666224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [C-peptide measurement in patients with type II diabetes mellitus: its possible use in the insulin therapy decision].
    Tamez-Pérez HE; García-Vallejo C; Santos-Flores R; González-Martínez PM; Lojero-Wheatley L; Valdovinos-Chávez S
    Arch Invest Med (Mex); 1990; 21(2):123-6. PubMed ID: 2103699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-peptide; new diagnostic tool in the evaluation of hypoglycaemic and hyperglycaemic states.
    Akhter J; Kayani N
    J Pak Med Assoc; 1992 Dec; 42(12):295-6. PubMed ID: 1299738
    [No Abstract]   [Full Text] [Related]  

  • 34. Pancreatic beta cell response in insulin treated NIDDM patients limitations of a random C-peptide measurement.
    Snehalatha C; Ramachandran A; Mohan V; Viswanathan M
    Diabete Metab; 1987 Feb; 13(1):27-30. PubMed ID: 3552773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C; Ramachandran A; Mohan V; Timothy H; Viswanathan M
    Horm Metab Res; 1986 Jun; 18(6):391-4. PubMed ID: 3525362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.